Stock Earnings

Question 1

Biomerieux SA의 주요 재무제표는 무엇인가요?

Accepted Answer

최신 재무제표(Form-10K)에 따르면, Biomerieux SA의 총 자산은 $5,770이며, 순profit입니다.

Question 2

BMXMF의 주요 재무 비율은 무엇인가요?

Accepted Answer

Biomerieux SA의 유동비율은 3.68이고, 순이익률은 10.85, 주당 매출은 $33.5입니다.

Question 3

Biomerieux SA의 매출은 부문 또는 지역별로 어떻게 나뉘나요?

Accepted Answer

Biomerieux SA largest revenue segment is Clinical Applications, at a revenue of 33,738,000,000 in the most earnings release.For geography, Americas is the primary market for Biomerieux SA, at a revenue of 2,054,199,999.

Question 4

Biomerieux SA은 수익성이 있나요?

Accepted Answer

yes, 최신 재무제표에 따르면 Biomerieux SA의 순profit은 $432입니다.

Question 5

Biomerieux SA에 부채가 있나요?

Accepted Answer

yes, Biomerieux SA의 부채는 1,565입니다.

Question 6

Biomerieux SA의 발행 주식은 몇 주인가요?

Accepted Answer

Biomerieux SA의 총 발행 주식은 117.92주입니다.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	4,121	3,979	3,674	3,589	3,376	3,118
Revenue Growth (YoY)	8%	8%	2%	6%	8%	17%
Cost of Revenue	1,802	1,764	1,617	1,580	1,375	1,364
Gross Profit	2,319	2,215	2,057	2,008	2,000	1,753
Selling, General & Admin	1,130	1,097	1,020	954	815	789
Research & Development	500	491	460	446	385	398
Operating Expenses	1,809	1,603	1,496	1,421	1,216	1,200
Other Non Operating Income (Expenses)	11	10	0	-2	1	1
Pretax Income	509	579	437	580	774	524
Income Tax Expense	138	154	114	140	175	121
Net Income	377	432	357	452	601	404
Net Income Growth	-8%	21%	-21%	-25%	49%	49%
Shares Outstanding (Diluted)	118.9	118.76	118.8	118.44	118.89	118.59
Shares Change (YoY)	0%	0%	0%	0%	0%	0%
EPS (Diluted)	3.17	3.63	3.01	3.82	5.06	3.41
EPS Growth	-8%	21%	-21%	-25%	48%	48%
Free Cash Flow	439	321	107	188	534	305
Free Cash Flow Per Share	3.69	2.7	0.9	1.58	4.49	2.57
Gross Margin	56.27%	55.66%	55.98%	55.94%	59.24%	56.22%
Operating Margin	12.35%	15.35%	15.26%	16.35%	23.22%	17.7%
Profit Margin	9.14%	10.85%	9.71%	12.59%	17.8%	12.95%
Free Cash Flow Margin	10.65%	8.06%	2.91%	5.23%	15.81%	9.78%
EBITDA	984	936	731	654	842	762
EBITDA Margin	23.87%	23.52%	19.89%	18.22%	24.94%	24.43%
D&A For EBITDA	475	325	170	67	58	210
EBIT	509	611	561	587	784	552
EBIT Margin	12.35%	15.35%	15.26%	16.35%	23.22%	17.7%
Effective Tax Rate	27.11%	26.59%	26.08%	24.13%	22.6%	23.09%

Biomerieux SA (BMXMF) Price

BMXMF Stock Price Chart

BMXMF Income

Follow-Up Questions